Dr Kenneth Anderson (Dana Farber Cancer Institute, Boston, USA) chairs a discussion with Prof Gareth Morgan (The Royal Marsden Hospital, London, UK) and Prof Paul Richardson (Harvard Medical School, Boston, USA) at Myeloma 2014 about the treatment of myeloma.
They discuss the trends in therapy they expect to see in the next decade and provide a response to the definitions workshop.